Robert Sisk, MD
Ophthalmology · Cincinnati, OHNPI 1063614089
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $38,059 of the $46,245 with a category attached, or 82.3%. 25 manufacturers reported payments, led by Eyepoint US, Inc. at 40.4% of the total. Reporting peaked in 2024 at $15,748 and has fallen 91.0% since, to $1,421 in 2025. Among ophthalmology clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 200 payments — averaging $231.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Eyepoint US, Inc.$19K
- Leica Microsystems Inc.$15K
- Astellas Pharma US Inc$3K
- Apellis Pharmaceuticals, Inc.$2K
- AbbVie$2K
- Regeneron Healthcare Solutions, Inc.$1K
- plus $3K from 19 others
Across 63 payments — averaging $12,449 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Biogen$302K
- Novartis$287K
- AbbVie$147K
- Spark Therapeutics, Inc.$49K
What the payments were for
- Consulting fees$38,05982%
- Speaking & faculty fees$1,9394%
- Food & beverage$6,24714%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Eyepoint US, Inc. | 19 | $18,706 |
| Leica Microsystems Inc. | 5 | $15,368 |
| Astellas Pharma US Inc | 15 | $3,119 |
| Apellis Pharmaceuticals, Inc. | 13 | $2,386 |
| AbbVie(2 entities) | 15 | $2,310 |
| Regeneron Healthcare Solutions, Inc. | 44 | $1,267 |
| Genentech USA, Inc. | 38 | $1,125 |
| Alimera Sciences, Inc. | 18 | $458 |
| Alcon | 2 | $247 |
| Novartis | 6 | $179 |
| Regeneron | 1 | $138 |
| Astellas US LLC | 1 | $136 |
| Carl Zeiss Meditec USA, Inc. | 1 | $135 |
| ANI Pharmaceuticals, Inc. | 4 | $118 |
| Spark Therapeutics, Inc. | 2 | $116 |
| Samsara Vision | 1 | $115 |
| Bausch & Lomb Americas Inc. | 5 | $93 |
| Biotissue Holdings Inc. | 2 | $57 |
| Notal Vision, Inc. | 1 | $47 |
| Biogen | 2 | $36 |
| Sandoz | 1 | $28 |
| Amgen | 1 | $17 |
| Oyster Point Pharma, Inc. | 1 | $17 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 1 | $13 |
| Lumibird Medical Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SURGICAL MICROSCOPES$10,750
- EYP-1901$10,175
- YUTIQ$8,208
- Proveo 8$4,600
- Izervay$2,695
- VABYSMO$401
- EYLEA HD$386
- OZURDEX$141
- ARTEVO 800$135
- SUSVIMO$133
- Syfovre$125
- Implantable Miniature Telescope$115
How this compares
$46,245 in reported general payments places this provider in the 95th percentile of 640 ophthalmology providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 225 | $9,489 |
| MoxifloxacinMoxifloxacin Hcl | 24 | $870 |
| Polymyxin B Sul-TrimethoprimPolymyxin B Sulf/Trimethoprim | 88 | $665 |
| Dorzolamide Hcl | 36 | $609 |
| Atropine Sulfate | 15 | $443 |
| Timolol Maleate | 20 | $257 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 37 | $221 |
| Ofloxacin | 16 | $203 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in Cincinnati
- Robert OsherCincinnati$720K
- Christopher RiemannCincinnati$463K
- Anup KhatanaCincinnati$347K
- Michael SnyderCincinnati$216K
- Daniel MillerCincinnati$75K
- Michael NordlundCincinnati$40K
- Adam KaufmanCincinnati$19K
- Haroon ChaudhryCincinnati$18K
- Karen KlugoCincinnati$17K
- Clara ChanCincinnati$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.